EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effects of Adenosine Triphosphate and Flunarizine on Erlotinib-Induced Ovarian Damage: An Experimental Study

Arzu Yavuz iD, Kemine Uzel iD, Esra Tuba Sezgin iD, Mehmet Kuzucu, Nesrin Yılmaz, Gülcenaz Yazici, Engin Hendem iD, Halis Süleyman iD

Life · 08.04.2026 · 16 (4) · 627

DOI: 10.3390/life16040627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 08.04.2026. Verfasst von Arzu Yavuz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, SBU Kocaeli City Hospital, Kocaeli 41380, Turkey. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

Erlotinib is a tyrosine kinase inhibitor (TKI) widely used in cancer therapy; however, its potential adverse effects on ovarian tissue have not been fully elucidated. The present study aimed to investigate erlotinib-induced ovarian injury and to evaluate the protective effects of adenosine triphosphate (ATP) and flunarizine, administered alone or in combination, using biochemical and histopathological analyses in a rat model. (2)

Methods

Thirty female rats were randomly allocated into five groups (n = 6 per group): healthy control, erlotinib, ATP + erlotinib, flunarizine + erlotinib, and ATP + flunarizine + erlotinib. ATP (5 mg/kg, intraperitoneal) and flunarizine (5 mg/kg, oral gavage) were administered daily for two weeks, while erlotinib (5 mg/kg) was given orally every two days for two weeks. Ovarian tissues were collected for oxidative stress analysis and histopathological evaluation, and blood samples were obtained for the measurement of serum prolactin and AMH levels. (3)

Results

Erlotinib administration resulted in significant oxidative stress and histopathological alterations in ovarian tissue, accompanied by a reduction in serum AMH levels, while prolactin levels remained unchanged. Treatment with ATP or flunarizine partially attenuated these alterations. (4)

Conclusions

Combined ATP and flunarizine administration showed stronger protective effects, improving biochemical parameters and preserving ovarian histology, suggesting a protective role against erlotinib-induced ovarian injury.

Schlagwörter

Stichwörter der Autor:innen

ATPerlotinibflunarizineovarian damage

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, SBU Kocaeli City Hospital, Kocaeli 41380, Turkey.
  • Anesthesia Program, Vocational School of Health Services, Erzincan Binali Yıldırım University, Erzincan 24030, Turkey.
  • Department of Biology, Faculty of Arts and Sciences, Erzincan Binali Yıldırım University, Erzincan 24030, Turkey.
  • Department of Obstetrics and Gynecology, Erzincan Binali Yıldırım University, Erzincan 24030, Turkey.
  • Department of Histology and Embryology, Faculty of Medicine, Erzincan Binali Yıldırım University, Erzincan 24030, Turkey.
  • Department of Medical Oncology, Mengucek Gazi Education and Research Hospital, Erzincan Binali Yıldırım University, Erzincan 24030, Turkey.

ORCID-Profile: Arzu Yavuz, Kemine Uzel, Esra Tuba Sezgin, Engin Hendem, Halis Süleyman

Zitieren

APA

Yavuz, A., Uzel, K., Sezgin, E. T., Kuzucu, M., Yılmaz, N., Yazici, G., Hendem, E., & Süleyman, H. (2026). Protective Effects of Adenosine Triphosphate and Flunarizine on Erlotinib-Induced Ovarian Damage: An Experimental Study. Life, 16(4), 627. https://doi.org/10.3390/life16040627

Vancouver

Yavuz A, Uzel K, Sezgin ET, Kuzucu M, Yılmaz N, Yazici G, et al. Protective Effects of Adenosine Triphosphate and Flunarizine on Erlotinib-Induced Ovarian Damage: An Experimental Study. Life. 2026;16(4):627. doi:10.3390/life16040627

BibTeX
@article{Yavuz2026,
  author = {Yavuz, Arzu and Uzel, Kemine and Sezgin, Esra Tuba and Kuzucu, Mehmet and Yılmaz, Nesrin and Yazici, Gülcenaz and Hendem, Engin and Süleyman, Halis},
  title = {Protective Effects of Adenosine Triphosphate and Flunarizine on Erlotinib-Induced Ovarian Damage: An Experimental Study},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {4},
  pages = {627},
  doi = {10.3390/life16040627}
}
Kostenlos starten →